Access to Quality Health Care
Improving access to health care in developing countries is a big challenge. Governments of rich and poor countries, intergovernmental agencies, NGOs and the pharmaceutical industry all have a role to play.
Improving access to health care in developing countries is a big challenge. Governments of rich and poor countries, intergovernmental agencies, NGOs and the pharmaceutical industry all have a role to play.
Biologicals
Biotech medicines are mostly prescribed by specialist doctors and administered by injection. Their molecular structure and properties are influenced by the manufacturing process.
Biotech medicines are mostly prescribed by specialist doctors and administered by injection. Their molecular structure and properties are influenced by the manufacturing process.
Counterfeit Medicines
The counterfeit drug trade is widespread, affecting both developing and developed countries. All medicines, both branded and generic, are at risk.
The counterfeit drug trade is widespread, affecting both developing and developed countries. All medicines, both branded and generic, are at risk.
Ethical Promotion
The IFPMA Code of Marketing Practices embodies a self-regulation approach to ensure the ethical promotion of medicines.
The IFPMA Code of Marketing Practices embodies a self-regulation approach to ensure the ethical promotion of medicines.
Genetic Resources
The IFPMA has established guidelines on Access to Genetic Resources and Equitable Sharing of Benefits Arising out of their Utilization.
The IFPMA has established guidelines on Access to Genetic Resources and Equitable Sharing of Benefits Arising out of their Utilization.
Health Care Systems
In many countries, health care systems play a major role in determining whether or not patients get access to a particular innovative medicine.
In many countries, health care systems play a major role in determining whether or not patients get access to a particular innovative medicine.
Improving Global Health
The pharmaceutical industry is voluntarily playing a key role in improving global health, particularly in developing countries.
The pharmaceutical industry is voluntarily playing a key role in improving global health, particularly in developing countries.
Intellectual Property & Patents
Strong patent and intellectual property rights are vital incentives for continuing innovation.
Strong patent and intellectual property rights are vital incentives for continuing innovation.
Pharmaceuticals & The Use of the Internet
The industry is finding ways for pharmaceutical information to be distributed appropriately to the right audiences via the Internet.
The industry is finding ways for pharmaceutical information to be distributed appropriately to the right audiences via the Internet.
Regulatory & Scientific Affairs
The duplication of testing and reporting required by different countries delays the availability of new drugs reaching patients.
The duplication of testing and reporting required by different countries delays the availability of new drugs reaching patients.
Research & Development
To reduce health care spending, many governments are often adopting "penny wise" policies to discourage the use of prescription drugs, which not only remove important drivers for innovation in the pharmaceutical sector, but also increase overall health care costs.
To reduce health care spending, many governments are often adopting "penny wise" policies to discourage the use of prescription drugs, which not only remove important drivers for innovation in the pharmaceutical sector, but also increase overall health care costs.
Trade
The industry is looking at ways to facilitate international trade in medicines, while ensuring quality and traceability.
The industry is looking at ways to facilitate international trade in medicines, while ensuring quality and traceability.